| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $141.8M | +66.3% |
| SG&A Expense | $31.1M | +4.0% |
| Operating Income | -$172.9M | -50.1% |
| Interest Expense | $3.1M | +319.4% |
| Net Income | -$151.8M | -35.5% |
| EPS (Basic) | -$2.89 | -0.7% |
| EPS (Diluted) | -$2.89 | -0.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $234.2M | -6.2% |
| Short-term Investments | $315.8M | +210.6% |
| Current Assets | $560.0M | +57.7% |
| Total Assets | $580.3M | +62.7% |
| Current Liabilities | $19.1M | +0.2% |
| Total Liabilities | $45.0M | +49.8% |
| Stockholders' Equity | $535.3M | +63.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.4M | -57.1% |
| Investing Cash Flow | -$223.6M | -250.4% |
| Financing Cash Flow | $353.3M | +38.2% |